Olema Oncology, Inc. (OLMA)
NASDAQ: OLMA · Real-Time Price · USD
7.36
-0.20 (-2.65%)
At close: Nov 16, 2026, 4:00 PM EST
7.50
+0.14 (1.90%)
After-hours: Nov 16, 2026, 6:58 PM EST
Olema Oncology Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Olema Oncology stock has a consensus rating of "Strong Buy" and an average price target of $35.5. The average 1-year stock price forecast is 382.34% higher than the current stock price, while the lowest is $13 (+76.63%) and the highest is $59 (+701.63%).
Price Target: $35.5 (+382.34%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Olema Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 9 | 9 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Buy Reiterates $18 → $13 | Buy | Reiterates | $18 → $13 | +76.63% | Nov 11, 2026 |
| Citi | Citi | Buy Maintains $59 | Buy | Maintains | $59 | +701.63% | Nov 11, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Initiates $35 | Buy | Initiates | $35 | +375.54% | Nov 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $36 | Buy | Maintains | $36 | +389.13% | Sep 21, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $16 | Buy | Maintains | $16 | +117.39% | Sep 19, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
19.98M
EPS This Year
-2.56
from -1.87
EPS Next Year
-2.90
from -2.56
EPS and Forward PE are based on non-GAAP adjusted numbers.